Faropenem Sodium Production Cost Reports

The report provides a detailed analysis essential for establishing a faropenem sodium production plant. It encompasses all critical aspects necessary for faropenem sodium production, including the cost of faropenem sodium production, faropenem sodium plant cost, faropenem sodium production costs, and the overall faropenem sodium production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a faropenem sodium production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Faropenem sodium is a broad-spectrum synthetic antibiotic that belongs to the penem class of medicines. It is primarily utilised as an antibiotic in the treatment of a variety of bacterial infections. It finds its main application in the treatment of respiratory tract infections, urinary tract infections, skin infections, and certain gynaecological infections caused by susceptible bacteria. It acts by binding with high affinity to penicillin-binding proteins (PBPs), particularly PBP-2 and PBP-1A, thereby inhibiting bacterial cell wall synthesis and exerting a bactericidal effect. In addition, it is widely used in hospitals and clinics as part of combination therapy for managing resistant infections, when common antibiotics do not provide the desired results. It also finds use in paediatric formulations for community-acquired infections. It also plays an important role in the development of combination drug therapies to improve antibacterial effectiveness. Additionally, it is used in medical research to study bacterial resistance patterns and to support the development of new antimicrobial treatments.

The primary factor that drives the demand for faropenem sodium is its application as a broad-spectrum antibiotic to treat various bacterial infections, which significantly supports its market expansion. Its application as an oral antibacterial drug for the treatment of respiratory tract infections like bronchitis, as well as urinary tract infections, including cystitis, also drives its demand in the pharmaceutical industry. Its usage in the treatment of skin and soft tissue infections, such as cellulitis and wounds, along with certain gynaecological infections, further promotes its demand in the medical and pharmaceutical industries.

Its involvement as a reference drug in the development of advanced antibacterial medicines and related healthcare products also supports its demand in the medical research and pharmaceutical production industries. Moreover, the rising prevalence of bacterial infections and the increasing focus on effective antimicrobial therapies continue to promote its market growth. Several factors, including the availability and cost of key raw materials and intermediates, compliance with pharmaceutical quality standards, and strict regulatory approvals significantly impact industrial faropenem sodium procurement. Manufacturing capabilities, supplier reliability, technological improvements in drug formulation, and well-managed distribution networks also play an important role in shaping its global procurement processes.

Raw Material for Faropenem Sodium Production

According to the faropenem sodium production plant project report, the major raw materials for faropenem sodium production include dichloromethane, triphenylphosphine, and sodium caprylate.

Production Process of Faropenem Sodium

The extensive faropenem sodium production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of faropenem sodium begins with dissolving the main intermediate in dichloromethane to form a clear solution. Then, triphenylphosphine and a solution of sodium caprylate in ethyl acetate are added to the intermediate solution. Then, the reaction system is purged with nitrogen to create an inert atmosphere, and a palladium catalyst is introduced to initiate the coupling reaction. The mixture is stirred at controlled room temperature under nitrogen until the reaction is complete. After completion, water is added to the solution to promote crystallisation, and the mixture is maintained at a moderate temperature before being further cooled to enhance solid formation. The resulting solid product is collected by filtration, washed with ethyl acetate to remove impurities, and finally dried under vacuum to obtain faropenem sodium as a white powder.

Faropenem sodium is the sodium salt form of faropenem, an orally active beta-lactam antibiotic belonging to the penem group, which is structurally a hybrid of penicillins and cephalosporins. It appears as a white to light yellow crystalline powder. The molecular formula of the compound is C12H14NNaO5S, and its molar mass is 307.30 g/mol. The boiling point of the compound is approximately 570.2 degrees Celsius at 760 mmHg and its flash point is around 298.7 degrees Celsius. It is freely soluble in water and methanol, and slightly soluble in ethanol. It is marketed under the brand name Farom in Japan, and under the brand name Orfanem in Bangladesh. It exhibits ultra-broad spectrum antibacterial activity against both aerobic and anaerobic gram-positive and gram-negative bacteria, and it is highly stable against various beta-lactamases, including extended-spectrum beta-lactamases. The compound should be stored under refrigerated or frozen conditions, and it is recommended to wear protective gloves and clothing while handling the substance, as direct contact may cause skin and eye irritation.